VT
BIIB icon

Vise Technologies’s Biogen BIIB Stock Holding History

Vise Technologies’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$953K Hold
5,415
– – 0.02% 604
2025
Q4 		$953K Buy
5,415
+2,616
+93% +$427K 0.02% 608
2025
Q3 		$392K Sell
2,799
-371
-12% -$50.1K 0.01% 785
2025
Q2 		$398K Buy
+3,170
New +$395K 0.02% 726
2024
Q4 		$250K Buy
+1,636
New +$276K 0.02% 679
2023
Q3 		– Sell
-716
Closed -$204K – 332
2023
Q2 		$204K Sell
716
-19
-3% -$5.66K 0.05% 324
2023
Q1 		$204K Buy
+735
New +$203K 0.05% 321

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vise Technologies's BIIB Position: Q1 2026 in Review

Vise Technologies held its Biogen (BIIB) position steady in Q1 2026 at 5,415 shares worth $953K. The position accounts for 0.02% of the portfolio, ranked #604.

Vise Technologies first reported a position in BIIB in Q1 2023 and has held it in 7 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Vise Technologies held 5,415 shares of Biogen worth $953K as of Q1 2026.
  • Vise Technologies left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.02% of Vise Technologies's portfolio in Q1 2026, its #604 holding.
  • Vise Technologies first reported a position in Biogen in Q1 2023 and has held it in 7 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.